Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities. Read more about Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Read more about The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies.
Utility of Human-Derived Models for Glioblastoma. Read more about Utility of Human-Derived Models for Glioblastoma.
RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon. Read more about RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2. Read more about The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Read more about Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer. Read more about Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer.
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation. Read more about The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
Targeting Autophagy in Cancer: Recent Advances and Future Directions. Read more about Targeting Autophagy in Cancer: Recent Advances and Future Directions.
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma. Read more about TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
